ATTR Amyloidosis, AL Amyloidosis, Cardiac Amyloidosis research hub

An open-label, multi-center, non-randomized pivotal Phase 3 study to evaluate the efficacy and safety of [18F]florbetaben Positron Emission Tomography (PET) imaging to diagnose cardiac AL amyloidosis

This study is testing a new type of imaging scan (called a PET scan) to see if it can accurately find a heart condition called cardiac AL amyloidosis. Researchers want to know if the scan can help doctors diagnose this condition more easily and quickly in adults.